Precision BioSciences, Inc. (DTIL)

Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	116.68	189.58	143.66	89.8	180.89
Short-Term Investments	11.9	0	0	0	0
Cash & Cash Equivalents	128.58	189.58	143.66	89.8	180.89
Cash Growth	-32.18%	31.96%	59.98%	-50.36%	75.29%
Receivables	0.9	0.72	0.49	10	0.97
Other Current Assets	6.88	8.81	17.6	5.77	11.82
Total Current Assets	136.36	199.11	161.75	105.56	193.67
Property, Plant & Equipment	14.6	13.78	29.33	41.5	39.57
Long-Term Investments	8.2	11.98	13.72	0	0
Goodwill and Intangibles	0.4	0.73	2.05	1.37	1.43
Other Long-Term Assets	0.23	12.57	4.64	1.72	0.56
Total Long-Term Assets	23.42	39.06	49.74	44.59	41.56
Total Assets	159.78	238.17	211.5	150.16	235.23
Accounts Payable	25.38	0.65	1.14	0.79	2.04
Deferred Revenue	95.12	139.06	98.26	84.16	82.38
Current Debt	1.13	1.68	1.82	1.93	0
Other Current Liabilities	-71.64	-81.73	-65.25	-44.06	-57.49
Total Current Liabilities	49.99	59.66	35.98	42.83	26.93
Long-Term Debt	7.72	23.28	7.29	8.59	0
Other Long-Term Liabilities	83.21	94.79	77.06	54.32	69.99
Total Long-Term Liabilities	90.93	118.07	84.35	62.9	69.99
Total Liabilities	140.92	177.74	120.33	105.73	96.92
Total Debt	8.86	24.96	9.11	10.52	0
Debt Growth	-64.52%	173.89%	-13.37%	-	-
Retained Earnings	-489.63	-428.31	-316.68	-286.07	-177.07
Shareholders' Equity	18.86	60.43	91.17	44.43	138.31
Net Cash / Debt	119.72	164.62	134.55	79.28	180.89
Net Cash / Debt Growth	-27.27%	22.35%	69.72%	-56.17%	75.29%
Net Cash Per Share	31.17	56.19	68.78	45.71	129.23
Working Capital	86.37	139.44	125.77	62.74	166.74
Book Value Per Share	4.91	20.63	46.60	25.61	98.82

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).